DIFFERENT TESTS / DIFFERENT ANSWERS
Blood levels, height and fat loss can’t rank the drugs
Tests measured hormone rises, height, fat and eating after surgery. Each result answers its own question. An axis is a set of linked hormones.
A fair comparison begins with what happened to the people
The studies measured blood hormones, height gain, fat or eating after surgery. The four drugs weren't tested against each other in the same experiment. Sermorelin, tesamorelin and CJC-1295 copy the hormone that starts growth hormone release. Ipamorelin acts through the appetite hormone, which can also prompt release.
CJC-1295 studies mainly followed blood levels and how long rises lasted. Sermorelin's direct older evidence concerns children with too little growth hormone. Tesamorelin trials checked fat changes in adults with a particular problem linked to HIV. Ipamorelin's human studies checked a brief blood rise and eating after bowel surgery.
First ask whether a study tested the benefit you want. Then ask whether the people had a health problem like yours. A high hormone reading doesn't prove that someone slept better. An animal finding cannot tell you how a person will respond.
A child's height gain cannot predict an older adult's fat loss. A smaller internal fat area doesn't necessarily mean lower total weight. A patient's chance of benefit stays uncertain when the study asks another question. None of these comparisons establishes equal amounts of the drugs for personal use.
The evidence ranges from blood tests to patient fat changes
| Drug | What the drug prompts | What changed or was checked | who took part |
|---|---|---|---|
| CJC-1295 | Growth hormone release | blood hormone rises, their duration and the continuing bursts | Small studies in healthy adults; separate animal tests [3][4][5][7] |
| Sermorelin | Growth hormone release | Children's yearly height gain; thinking and fat findings with another drug | Children with low growth hormone; doctors' views; older adults taking tesamorelin [8][9][10][11] |
| Tesamorelin | Growth hormone release | Internal belly fat, liver fat, blood hormones and muscle, bone and other tissue | mainly adults who have HIV and excess deep belly fat [12][14][15][16] |
| Ipamorelin | Growth hormone release through the appetite hormone | Brief blood rise; no proven improvement in eating after surgery; separate weight and bone findings | Healthy volunteers, bowel surgery patients, ferrets and rats [17][18][19][20][21] |
The evidence doesn't show which drug would help you most. The scientists used different tests in people with different health problems. A fair ranking would need the same health question tested in similar people. Picking the largest figure won't supply that missing comparison.
Four sorts of number describe different changes in the body
A doubled reading means a one-hundred-percent rise. The added amount equals the whole starting amount. A final reading and the amount added are therefore different. CJC-1295 papers also measured low blood readings separately from averages [4][5].
A scanned area differs from a percent of that area. A 42 square centimeter fall describes less deep belly fat seen on a scan [14]. An eighteen-percent fall means that share of the starting deep belly fat area disappeared [16]. Without the starting scanned area, you cannot know what percent the first fall represents.
A fall in a percentage reading differs from the share of fat lost. For example, a liver fat reading falling from ten percent to five percent drops five percentage points. The fat reading also halves, so the fall is fifty percent of the starting reading. That is an arithmetic example, rather than a patient result from the tesamorelin review [12].
Blood timing tells you more than a single reading. A hormone burst has a high point and then falls. Adding blood levels over time accounts for how high the levels stayed and how long. Longer raised levels don't necessarily mean a higher peak or more bursts [5][7].
The clearest fat evidence still concerns adults who have HIV
Tesamorelin trials found less internal belly fat in specific adults who have HIV [12]. That finding concerns a patient change rather than just a blood test. CJC-1295 studies chiefly found higher blood hormones and changed blood proteins [3][4][5]. Those tests didn't prove better daily health for you.
Sermorelin's direct older trial found faster growth in children with a hormone shortage [11]. Doctors' views about broader adult uses weren't tests of those benefits [9][10]. Ipamorelin produced a brief hormone rise in healthy volunteers [20]. The bowel surgery trial didn't establish earlier eating with the drug [19].
Ipamorelin studies also found less weight loss in ferrets and faster bone growth in rats [17][21]. Those animal changes need tests in people before anyone can claim the same benefit, because your question concerns a change in human health rather than what happened to a rat or ferret. A useful animal finding can still leave that human question open.
Combining several trials can make an average result less uncertain. That depends on how well the trials answer the same question. The combined result still concerns only the patients and treatments studied. Stronger evidence for one use cannot establish benefit for every other use.
These comparisons can’t establish your treatment amount or timing
The studies don't compare the drugs closely enough to establish equal treatment amounts. They cannot give you a personal amount or timetable. Different forms of a drug may remain active for different lengths of time. A blood protein attachment can extend a drug's stay in the body.
You can still judge whether a finding addresses your health question. A scan of fat, a blood level and a time to eating measure different changes. A percent rise compares a reading with its own starting level. Comparing unlike numbers cannot tell you which drug will improve health most.
The cited papers identify the studies behind each numbered note. The drug pages explain which people or animals took part. A doctor's opinion offers reasons for a view rather than a tested benefit. None of those findings replaces medical care from someone familiar with your health.